Stevanato Group S.p.A STVN
NYSE STVN
$22.60 +0.25 (+1.12%)
At close: Aug 21, 2026 · 4:00 PM EDT

Stevanato Group S.p.A (STVN) Cash from Investing Activities (2020 - 2026)

Stevanato Group S.p.A (STVN) posted quarterly Cash from Investing Activities of -$82.4 million for Q1 2026, down 10.81% year-over-year from -$92.4 million in Q1 2025, and up 25.0% quarter-over-quarter from -$109.9 million in Q4 2025.

Stevanato Group S.p.A (STVN) Cash from Investing Activities (2020 - 2026) Analysis & Trends

Stevanato Group S.p.A (STVN) has reported Cash from Investing Activities for 7 consecutive years, with -$82.4 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash from Investing Activities fell 10.81% year-over-year to -$82.4 million; the TTM figure through Mar 2026 stood at -$316.2 million (down 5.85% YoY), while the FY2025 annual figure was -$317.7 million, up 4.17% from the prior year.
  • Cash from Investing Activities advanced to -$82.4 million in Q1 2026 per STVN's latest filing, from -$109.9 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$43.6 million in Q3 2022 and bottomed at -$143.9 million in Q3 2023.
  • Historically, Cash from Investing Activities has averaged -$84.6 million across 5 years, with a median of -$81.3 million in 2022.
  • Annual changes were most pronounced in 2023 — Cash from Investing Activities sank 230.4% — and 2024, when it surged 63.68%.
  • Stevanato Group S.p.A's Cash from Investing Activities stood at -$70.3 million in 2022, then slumped by 41.27% to -$99.3 million in 2023, then grew by 2.08% to -$97.2 million in 2024, then decreased by 13.0% to -$109.9 million in 2025, then gained by 25.0% to -$82.4 million in 2026.
  • Business Quant data shows STVN's Cash from Investing Activities at -$82.4 million in Q1 2026, -$109.9 million in Q4 2025, and -$56.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn -26.60 Mn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn -241.00 Mn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -222.00 Mn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn -383.65 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn -461.00 Mn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn -43.20 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn -87.00 Mn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -90.00 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn -117.00 Mn
10 Stevanato Group S.p.A 6.18 Bn 6.07 Bn 100.91 Mn -74.26 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -74.26 Mn
Jun 30, 2026 -74.26 Mn
Mar 31, 2026 -82.42 Mn
Mar 31, 2026 -82.42 Mn
Dec 31, 2025 -109.89 Mn
Dec 31, 2025 -109.89 Mn
Sep 30, 2025 -56.35 Mn
Sep 30, 2025 -56.35 Mn
Jun 30, 2025 -67.58 Mn
Jun 30, 2025 -67.58 Mn
Mar 31, 2025 -74.38 Mn
Mar 31, 2025 -74.38 Mn
Dec 31, 2024 -97.24 Mn
Dec 31, 2024 -97.24 Mn
Sep 30, 2024 -52.28 Mn
Sep 30, 2024 -52.28 Mn
Jun 30, 2024 -74.84 Mn
Jun 30, 2024 -74.84 Mn
Mar 31, 2024 -110.93 Mn
Mar 31, 2024 -110.93 Mn